News

Paul Atkins, nominated by Trump, has been sworn in as SEC chair
Paul Atkins was sworn into office as the 34th chairman of the Securities and Exchange Commission. Paul Atkins has officially ...
Paul Atkins sworn in as US SEC chair
Paul Atkins, who previously served as a U.S. Securities and Exchange Commission member from 2002 to 2008 and was seen as a ...
BitFuFu Files 2024 Annual Report on Form 20-F
BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced that it has ...
The Manila Times5h
Sight Sciences to Debut OMNI® Edge Surgical System at the 2025 ASCRS Annual Meeting, Expanding the OMNI Product Portfolio
OMNI Edge with TruSync™ technology builds on the proven performance of the OMNI ® Surgical System and introduces a ...
Crypto firms gave $18M to Trump’s inauguration, Ripple’s $4.9M gift was second biggest overall
Ripple's $4.9 million was the second largest donation to the president's fund. Only Pilgrim's, a poultry producer, outspent ...
CoinDesk10hOpinion
5 Ways the SEC Can Embrace Innovation
Tuongvy Le, a former senior SEC attorney, lays out an agenda for the world’s most important regulator to stay ahead of the ...
The Manila Times11h
Roadzen Inc. Files Multi-Million Dollar Lawsuit Against Meteora for Breach of Contract to the Terms of the Forward Purchase Agreement
The lawsuit stems from a Forward Purchase Agreement (FPA) signed in August 2023, under which, as stated in the complaint, Meteora acquired 5 million shares in Roadzen at effectively a zero-cost basis.
Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering ...